Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-06-14
2005-06-14
Shukla, Ram R. (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023100, C536S023520
Reexamination Certificate
active
06906041
ABSTRACT:
The invention concerns the use of a nucleic acid capable of expressing beta-interferon for the preparation of a pharmaceutical composition for the treatment of an immune disease.
REFERENCES:
patent: 5580859 (1996-12-01), Felgner et al.
patent: 6359054 (2002-03-01), Lemieux et al.
Youssef et al. The Journal of Immunology 161:3870-3879, 1998.
Hernberg et al., Lyphocytes subsets as prognostic markers for cancer patients receiving immunomodulative therapy. 1999. Medical Oncology, vol. 16, pp. 145-153
Martino et al., Cytokine therapy in immune-mediated demyelinating diseases of the central nervous systems a novel gene therapy approach 2000 Jouranl of Neuroimmunology, vol. 107, pp. 184-190.
Crystal, Transfer of Genes to Humans: Early Lessons and Obstacles to Success, Oct. 20, 1995. Science vol. 270 pp. 404-409.
Anderson Human gene therapy Apr. 30, 1998 vol. 392 Nature pp. 25-30.
Triantaphyllopoulos et al. Cloning and expression of murine IFNB and a TNF antagonist for gene therapy of experimental allergic encephalomtelitis pp. 253-263 1998.
Ludovic et al. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-Cationic liposome complex into the central nervous system1 pp. 5181-5187 1998.
Triantaphyllopoulos et al. Amelioration of collagen-induced arthritis and suppression of interferon-y, interleukin-13 and tumor necrosis factor a production by interferon-B gene therapy pp. 90-99 1999.
Deonarain Ligand-targeted receptor-mediated vectors for gene delivery pp 53-69 1998.
Verma et al. Gene therapy promises, problems and prospects pp. 239-242 vol. 389 1997.
Shukla Ram R.
Transgene S.A.
LandOfFree
Treatment of immune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of immune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immune diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3482785